Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 May 15;587(Pt 10):2387-97.
doi: 10.1113/jphysiol.2009.169078. Epub 2009 Mar 30.

Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men

Affiliations
Randomized Controlled Trial

Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men

Charlotte Brøns et al. J Physiol. .

Abstract

A high-fat, high-calorie diet is associated with obesity and type 2 diabetes. However, the relative contribution of metabolic defects to the development of hyperglycaemia and type 2 diabetes is controversial. Accumulation of excess fat in muscle and adipose tissue in insulin resistance and type 2 diabetes may be linked with defective mitochondrial oxidative phosphorylation. The aim of the current study was to investigate acute effects of short-term fat overfeeding on glucose and insulin metabolism in young men. We studied the effects of 5 days' high-fat (60% energy) overfeeding (+50%) versus a control diet on hepatic and peripheral insulin action by a hyperinsulinaemic euglycaemic clamp, muscle mitochondrial function by (31)P magnetic resonance spectroscopy, and gene expression by qrt-PCR and microarray in 26 young men. Hepatic glucose production and fasting glucose levels increased significantly in response to overfeeding. However, peripheral insulin action, muscle mitochondrial function, and general and specific oxidative phosphorylation gene expression were unaffected by high-fat feeding. Insulin secretion increased appropriately to compensate for hepatic, and not for peripheral, insulin resistance. High-fat feeding increased fasting levels of plasma adiponectin, leptin and gastric inhibitory peptide (GIP). High-fat overfeeding increases fasting glucose levels due to increased hepatic glucose production. The increased insulin secretion may compensate for hepatic insulin resistance possibly mediated by elevated GIP secretion. Increased insulin secretion precedes the development of peripheral insulin resistance, mitochondrial dysfunction and obesity in response to overfeeding, suggesting a role for insulin per se as well GIP, in the development of peripheral insulin resistance and obesity.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overview of study activities
The study was designed as a cross-over study where the subjects received the diet in a randomized order. *Data not included.
Figure 2
Figure 2. Basal hepatic glucose production and insulin resistance index and insulin stimulated glucose disposal
A, hepatic glucose production (HGP) in the basal state. B, calculated hepatic insulin resistance index in the basal state. C, insulin stimulated glucose disposal, i.e. the clamp M-value. Control diet (grey) and HFHC diet (black). Data are means ±s.e.m. *P≤ 0.05, **P≤ 0.005.
Figure 3
Figure 3. AUC (0–30 min) for blood glucose, serum insulin and C-peptide during the IVGTT
Filled squares, HFHC diet; filled triangles, control studies. Data are means ±s.d., *P≤ 0.05.
Figure 4
Figure 4. Oxidative phosphorylation and PGC-1α gene expression
Expression of key oxidative phosphorylation genes as well as PGC-1α gene expression in response to control diet (grey) and HFHC diet (black) for the basal state (A) and during insulin stimulation (B). Data are means ±s.d.

References

    1. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care. 2007;30:89–94. - PubMed
    1. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Haring HU, Jacob S. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes. 2001;50:2579–2584. - PubMed
    1. Befroy DE, Petersen KF, Dufour S, Mason GF, de Graaf RA, Rothman DL, Shulman GI. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes. 2007;56:1376–1381. - PMC - PubMed
    1. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, DeFronzo RA, Cusi K. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 2005;54:1640–1648. - PubMed
    1. Bergman RN, Finegood DT, Kahn SE. The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest. 2002;32(Suppl 3):35–45. - PubMed

Publication types

MeSH terms